GENPF (Genix Pharmaceuticals) Total Operating Expense: $0.09 Mil (TTM As of Jan. 2026)


What is Genix Pharmaceuticals Total Operating Expense?

Genix Pharmaceuticals GENPF Total Operating Expense is $0.09 Mil as of Jan. 2026. The stock has 3 warning signs investors should review.

Genix Pharmaceuticals's Total Operating Expense for the three months ended in Jan. 2026 was $0.02 Mil. Genix Pharmaceuticals's Total Operating Expense for the trailing twelve months (TTM) ended in Jan. 2026 was $0.09 Mil.

Genix Pharmaceuticals Total Operating Expense Related Terms

Genix Pharmaceuticals Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Genix Pharmaceuticals's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genix Pharmaceuticals Total Operating Expense Chart

Genix Pharmaceuticals Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.33 0.75 0.65 0.18 0.11

Genix Pharmaceuticals Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.02 0.03 0.02 0.02

Genix Pharmaceuticals Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $0.09 Mil mean?
Genix Pharmaceuticals (GENPF) has a Total Operating Expense of $0.09 Mil as of Jan. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Genix Pharmaceuticals and its competitors.
Is Genix Pharmaceuticals' Total Operating Expense too high?
Genix Pharmaceuticals' current Total Operating Expense is $0.09 Mil.
How does Genix Pharmaceuticals' Total Operating Expense compare to ZTS and UTHR?
Genix Pharmaceuticals' Total Operating Expense of $0.09 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Genix Pharmaceuticals and its competitors. Genix Pharmaceuticals's current Total Operating Expense is $0.09 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genix Pharmaceuticals stock overvalued right now?
Genix Pharmaceuticals (GENPF) has a current Total Operating Expense of $0.09 Mil. The current Total Operating Expense is $0.09 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Genix Pharmaceuticals (GENPF), the current Total Operating Expense is $0.09 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genix Pharmaceuticals Business Description

Other Exchanges GENX:Canada
Address 1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 1J8
Genix Pharmaceuticals Corp is a Canadian life sciences company focused on the research, development, manufacturing, sales, and distribution of novel, branded generic ophthalmic drugs, and ophthalmic OTC products. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its ophthalmic products portfolio comprises different kinds of eye ointments (pending approval), and eye drops. Geographically the company operates only in Canada.